ArticleMolecular diagnosis & therapy2019

Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma.

Minjuan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.